NCT07625917 Feasibility of Internet-based HIV Prevention Research
| NCT ID | NCT07625917 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Montefiore Medical Center |
| Condition | HIV Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 500 participants |
| Start Date | 2025-08-01 |
| Primary Completion | 2028-05-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500 participants in total. It began in 2025-08-01 with a primary completion date of 2028-05-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will use social media to recruit a diverse sample of people who self-report injecting drugs, assessing the feasibility of online assessments and participants' ability to perform at-home self-administered HIV testing. Participants will complete online questionnaires at baseline and will be mailed HIV testing kits that they will self-administer and mail to a central laboratory. Investigators will track completion of questionnaires and whether at-home self-administered HIV tests were completed and sent to the laboratory.
Eligibility Criteria
Inclusion Criteria: * 18 years or older * US residency * English or Spanish fluency * injection drug use (self-report, past 30 days) * basic reading comprehension Exclusion Criteria: * HIV status known to be positive
Contact & Investigator
Aaron Fox
PRINCIPAL INVESTIGATOR
Montefiore Medical Center/Albert Einstein College of Medicine
Frequently Asked Questions
Who can join the NCT07625917 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying HIV Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07625917 currently recruiting?
Yes, NCT07625917 is actively recruiting participants. Contact the research team at guillermo.sanchezfat@einsteinmed.edu for enrollment information.
Where is the NCT07625917 trial being conducted?
This trial is being conducted at The Bronx, United States.
Who is sponsoring the NCT07625917 clinical trial?
NCT07625917 is sponsored by Montefiore Medical Center. The principal investigator is Aaron Fox at Montefiore Medical Center/Albert Einstein College of Medicine. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.